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Do disease specific characteristics add to the
explanation of mobility limitations in patients with
different chronic diseases? A study in the
Netherlands
Didi M W Kriegsman, Dorly J H Deeg, Jacques Th M van Eijk, Brenda W J H Penninx,
A Joan P Boeke
Abstract
Study objectives-To determine whether
disease specific characteristics, reflecting
clinical disease severity, add to the expla-
nation of mobility limitations in patients
with specific chronic diseases.
Design and setting-Cross sectional study
of survey data from community dwelling
elderly people, aged 55-85 years, in the
Netherlands.
Participants and methods-The addi-
tional explanation of mobility limitations
by disease specific characteristics was
examined by logistic regression analyses
on data from 2830 community dwelling
elderly people.
Main results-In the total sample, chronic
non-specific lung disease, cardiac disease,
peripheral atherosclerosis, diabetes melli-
tus, stroke, arthritis and cancer (the index
diseases), were all independently associ-
ated with mobility limitations. Adjusted
for age, sex, comorbidity, and medical
treatment disease specific characteristics
that explain the association between dis-
ease and mobility mostly reflect decreased
endurance capacity (shortness of breath
and disturbed night rest in chronic non-
specific lung disease, angina pectoris and
congestive heart failure in cardiac dis-
ease), or are directly related to mobility
function (stiffness and lower body com-
plaints in arthritis). For atherosclerosis
and diabetes mellitus, disease specific
characteristics did not add to the explana-
tion of mobility limitations.
Conclusions-The results provide evi-
dence that, to obtain more detailed infor-
mation about the differential impact of
chronic diseases on mobility, disease spe-
cific characteristics are important to take
into account.
(_ Epidemliol Community Health 1 997;51:676-685)
The role of chronic diseases as determinants of
mobility limitations is intuitively important,
but not well defined. A higher number of
chronic diseases is consistently associated with
a higher prevalence of mobility limitations,1 3
and longitudinally with a higher incidence of
mobility loss.4 However, these associations do
not provide information on the influence of
different specific chronic diseases. Recently,
more studies have been focused on associations
between specific chronic diseases and
mobility.` In elderly people, the specific
chronic diseases that are most consistently
associated with either a higher prevalence or
higher incidence of mobility limitations include
arthritis,2 6-9 cardiac diseases,2 4 7 9 cerebrovas-
cular disorders,2 4 6-8 chronic obstructive pul-
monary disease, 79 diabetes mellitus2 4 8 9and, to
a lesser extent, cancer2 8 9and atherosclerosis.-
It may, however, be doubted whether cur-
rently used measurements of chronic diseases
are sufficiently detailed to obtain accurate
information on the associations between spe-
cific chronic diseases and mobility. The meas-
urement of chronic diseases in population sur-
veys is mostly confined to self reports
pertaining to the presence or absence of a spe-
cific disease. The accuracy of patients' self
reports regarding the presence of chronic
diseases is generally considered adequate,
although this was shown to be different for
specific chronic conditions.'-3 It has been
stated that the clinical severity of the disease
should be taken into account in studies on the
associations between specific chronic diseases
and mobility.4 6
Methods that are used by physicians in clini-
cal practice can be of value in the assessment of
clinical severity of chronic diseases. Physicians
implicitly judge the clinical severity of a disease
in their patients according to the presence of
disease specific signs and symptoms. In acquir-
ing the necessary knowledge, medical history
questions are of primary importance. This is
particularly the case for most chronic diseases.
Surprisingly, the use of medical history ques-
tions, conditional on disease presence, as a
method of improving the explanation of mobil-
ity limitations in survey studies has never been
systematically evaluated. Information about
the additional influence of these parameters of
clinical severity is important for epidemiologi-
cal research and health planning by providing a
more detailed measure of chronic diseases that
can be used to obtain a more precise picture of
the burden of disease for both individuals and
populations, and its association with outcome
measures, such as mobility limitations. When
the presence of certain disease specific symp-
toms, reflecting clinical severity, would seem
to be strongly associated with mobility
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limitations, it may be possible to increase the
accuracy ofpredictions for the future regarding
the prevalence of mobility limitations, disabil-
ity, and the use of health care facilities. In addi-
tion, intervention strategies directed at particu-
larly those parameters of clinical severity of
specific chronic diseases with the strongest
associations with health outcomes may be
developed to diminish the negative conse-
quences of chronic diseases in the future.
In this study, we investigate whether the
explanation of mobility limitations can be
improved by adding questions directed at
assessment of clinical severity, conditional on
the self reported presence of a specific chronic
disease. The influence of these parameters of
clinical disease severity on the associations
between chronic diseases and mobility limita-
tions is examined for several chronic diseases
that often afflict the elderly, and that have been
repeatedly shown to influence physical func-
tioning and thereby the ability of older people
to live independently in the community. Seven
specific chronic diseases with a high prevalence
in the elderly population were selected: chronic
non-specific lung disease (asthma, chronic
bronchitis or pulmonary emphysema), cardiac
disease (including myocardial infarction), pe-
ripheral atherosclerosis, cerebrovascular acci-
dent, diabetes mellitus, arthritis (rheumatoid
arthritis or osteoarthritis) and malignant neo-
plasms.
The following questions will be considered:
(1) Does the self reported presence of
specific chronic diseases explain self reported
mobility limitations in community dwelling
elderly people?
(2) Does the presence of signs and symp-
toms, reflecting clinical disease severity, add to
the explanation of mobility limitations in
patients with a specific chronic disease?
Methods
This study uses a cross sectional design. The
data were collected as part of the first data col-
lection cycle of the Longitudinal Aging Study
Amsterdam (LASA),'4 a 10 year longitudinal
study on predictors and consequences of
changes in physical, cognitive, emotional, and
social functioning in older persons.
HYPOTHESES
For the first research question, we expected the
association with mobility limitations to be most
pronounced for those chronic diseases ofwhich
the clinical picture is characterised by symp-
toms of the locomotor system (stroke and
arthritis), or by decreased endurance capacity
(chronic non-specific lung disease, cardiac dis-
ease). The associations of the other specific
chronic diseases (peripheral atherosclerosis,
diabetes mellitus, and cancer) with mobility
limitations are expected to be less pronounced.
The inclusion of disease specific parameters
of clinical severity, as measured by medical his-
tory questions, is hypothesised to add to the
explanation of mobility limitations especially in
those chronic diseases that have the strongest
association with mobility limitations. The
symptoms that are expected to add most, are
those that most directly affect physical func-
tioning (for example, symptoms of the lower
body joints in patients with arthritis, and loco-
motor sequelae in stroke victims), or endur-
ance capacity (for example, shortness of breath
in patients with chronic non-specific lung
disease, congestive heart failure in patients with
cardiac disease). On the other hand, disease
specific symptoms that are not directly associ-
ated with the locomotor system (for example,
aphasia in stroke victims), or with endurance
capacity (for example, having ever had wheez-
ing breath, or a history of a recent exacerbation
in patients with chronic non-specific lung
disease, or a history of myocardial infarction in
patients with cardiac disease) are not expected
to add significantly to the explanation of
mobility limitations.
STUDY POPULATION
A sample of people aged 55 to 85 years, strati-
fied by age and sex according to expected attri-
tion resulting from mortality at mid-term of
LASA (after five years) in each age group, was
drawn from the population registries of 11
municipalities in three culturally distinct geo-
graphical areas in the Netherlands. The cohort
was recruited in 1991 for the NESTOR-LSN
study "Living arrangements and social net-
works of older adults" (response rate 62.3%).'5
Although there was a decline in response with
increasing age (p<0.05), the stratification has
ensured representativity on age, sex, and level
of urbanisation of the sample.'5 After 11
months, the participants in NESTOR-LSN
were approached for the first LASA cycle.
From the initial sample of 3805 persons who
participated in NESTOR-LSN, a total of 3107
participated in the main interview of LASA
(81.7%). Data were collected in the period
from September 1992 through October 1993.
Details of the procedures and results of the
field work are described elsewhere.'6 Of the
persons who did not participate, 260 (6.8% of
initial sample) proved to be ineligible (de-
ceased or not able because of severe physical or
cognitive disturbances, or both). Of the other
438 non-participants, 394 (10.4% of initial
sample) refused and 44 (1.2% of initial sample)
could not be contacted. The corrected re-
sponse percentage, excluding those who were
ineligible after all, therefore was 87.6%. Older
KEY POINTS
* Self reports of chronic diseases are insuf-
ficient measures to explain mobility limi-
tations in elderly people.
* Symptoms reflecting clinical disease se-
verity add to the explanation of mobility
limitations.
* Use of medical history questions is an
adequate and cheap method to obtain
information about the clinical severity of
chronic diseases in survey studies.
* The accuracy of future predictions re-
garding prevalence of disability may be
improved by using information from
medical history questions.
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age was significantly associated with refusal to
participate (p<0.001) and ineligibility because
of severe physical or cognitive disturbances
(p<0.0001). Excluded for this study were par-
ticipants who, at the time of the main interview,
were institutionalised (living in a residential or
nursing home or in a psychiatric hospital;
n=126), and those who were living independ-
ently but were unable to complete the full
interview (n=151), leaving a total number of
2830 (91.1% of all participants). As a result,
the study population is a comparatively healthy
selection of the original sample, although the
stratified sampling frame guaranteed that suffi-
cient numbers of subjects in the highest age
group, as well as subjects with physical
problems, were included.
MEASUREMENTS
Determinants
The presence of chronic diseases was assessed
by asking the participants explicitly whether
they had any of the following seven chronic
diseases: chronic non-specific lung disease
(asthma, chronic bronchitis or pulmonary
emphysema), cardiac disease (including myo-
cardial infarction), peripheral atherosclerosis,
cerebrovascular accident, diabetes mellitus,
arthritis (rheumatoid arthritis or osteoarthri-
tis), and malignant neoplasms. If a disease was
reported present, additional questions were
asked concerning medical treatment (as a
potential confounder) and disease specific
symptoms and signs reflecting clinical severity
of the disease. Pertinent medical history ques-
tions (questions that physicians use to get an
impression of disease severity) were selected in
close cooperation with general practitioners
with expert knowledge on the specific chronic
diseases. As far as possible, the items were
derived from existing questionnaires such as
the Rose Questionnaire for cardiac disease.'7
For malignancies, a radiation oncologist was
consulted. Table 1 presents the variables used
in the analyses, as well as the absolute numbers
of subjects in the "yes" category.
For cardiac diseases, the answers to the dis-
ease specific questions were used to distinguish
separate diagnoses. The symptoms of diabetes
mellitus pertained to the presence of diabetic
complications: macrovascular complications
(angina pectoris or intermittent claudication,
or both), retinopathy, and peripheral neuropa-
thy. For stroke, the presence of specific seque-
lae was included, namely locomotor disabili-
ties, visual handicap, and expressive (such as
difficulties in finding words) or perceptive
(understanding written text) aphasia. For
arthritis, both the presence of symptoms and
the extent of joint involvement, as well as a his-
tory of joint surgery were taken into account.
Because the numbers of respondents with a
specific primary malignancy were too small to
include them separately, malignancies were
categorised according to overall five year
survival rates after diagnosis.'8 When the
patient reported to have had two or more
primary tumours, the category was based on
the tumour with the worst prognosis.
The presence of other chronic diseases was
assessed by asking respondents whether they
had, at the moment of the interview, any other
chronic disorder of at least three months' dura-
tion in addition to those that were explicitly
asked. The category "other chronic diseases"
includes, among others, neurological diseases,
osteoporosis, neck and back problems, liver
and kidney diseases, endocrinological diseases,
varicose veins and venous insufficiency, hyper-
tension, gastrointestinal diseases, allergies,
consequences of accidents or surgery, chronic
locomotor problems not covered elsewhere,
dizziness, anaemia, disorders of the eyes or
ears, and mental disorders.
Outcome measure
The presence of mobility limitations was
assessed using three self report items pertain-
ing to mobility activities in daily life: ability to
walk up and down a 15 step staircase without
stopping, use of private or public transporta-
tion, and cut own toenails. Answers on each
item were originally coded as 0 "can be
performed without difficulty", 1 "can be
performed, but with difficulty", 2 "can only be
performed with help" or 3 "cannot be per-
formed at all". Based on the results of pilot
studies,'9 these items were shown to constitute
the best scale out of a set of nine items. The
selection of the three items was based on itera-
tive reliability analysis, in which the items with
the highest item rest correlation were retained
without an important influence on the reliabil-
ity coefficient. To determine whether the three
mobility items, which cover a range of mobility
related activities necessary to maintain au-
tonomy in daily life, are equally important for
the underlying dimension "mobility limita-
tions" in subjects with specific chronic dis-
eases, additional analyses were performed.
Factor analyses were conducted for the three
mobility items for each chronic disease sepa-
rately, including only those subjects who
reported to have only one of the specific
chronic diseases. In this way, the relative
importance of the separate items as part of the
underlying dimension "mobility limitations"
could be compared. The factor structure
proved to be comparable between the specific
chronic diseases, and was not different from
that in subjects without any disease. Thus, the
separate mobility items can be considered to
represent a general underlying dimension for
subjects with different diseases, and summing
the three item scores results in a global index of
mobility limitations, which is equally valid for
each of the specific chronic diseases studied.
Although the reliability of this three item
mobility scale in the total study population was
adequate (Cronbach's ca 0.72), and all items
loaded on one factor (all factor loadings
>0.75), use of a total score in linear regression
analysis was precluded by an extremely skewed
frequency distribution with >60% having a
total score of 0 (range 0-9), and a non-random
distribution of the residuals after multiple
linear regression with the score on the mobility
scale as the dependent variable. Therefore, the
mobility scale was dichotomised into codes 0
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Table 1 Variables used in the analyses
Variables Criteria No Yes
316Chronic non-specific lung
disease
Medical treatment
Daily cough
Daily phlegm production
Exacerbation past year
Shortness of breath
Wheezing breath ever
Wheezing breath during rest
Disturbed night rest
Cardiac disease
Medical treatment
Myocardial infarction
Angina pectoris
Other ischaemic heart disease
Congestive heart failure
Valvular disease
Cardiac pacemaker
Other cardiac disease
Atherosclerosis
Medical treatment
Intermittent claudication
Arterial surgery
Other peripheral artery
disease
Diabetes mellitus
Medical treatment
Macrovascular complications
Diabetic retinopathy
Diabetic neuropathy
Stroke
Medical treatment
¢ 2 strokes
Locomotor sequelae
Visual sequelae
Expressive aphasia
Perceptive aphasia
Arthritis
Medical treatment
Joint pain past 3 months
Joint stiffness past 3 months
Joint swelling past month
Complaints lower body joints
Complaints upper body joints
Joint surgery lower body
Joint surgery upper body
Malignancies
Medical treatment
_ 2 primary tumours
Prognostic category:
Excellent
5-years survival >50%
5-year survival S 50%
Haematogenous metastases
Surgical treatment
Chemotherapy
Radiation therapy
Other variables:
Other chronic disease
Use of prescribed drugs and/or regular contact with physician for chronic non-specific lung disease
Yes
Yes
Yes
During light exertion or at rest
Yes
Yes
Often or always
Use of prescribed drugs and/or regular contact with physician for cardiac disease
Ever had myocardial infarction
Pain, or heavy, uncomfortable feeling on the chest during exertion, disappearing within 10 minutes
after stopping or taking sublingual nitroglycerine, or avoidance of exertion because of chest-pain
History of coronary artery surgery (including dotter procedure) without myocardial infarction and
without symptoms of angina pectoris
Sleeping with >1 pillow because of shortness of breath and/or oedema of ankles, feet or legs when
waking up in the morning
History of valvular surgery
History of pacemaker implantation
Not fitting in any of the categories described above (for example: relatively benign arrhythmia,
valvular lesions without a history of surgery)
Use of prescribed drugs and/or regular contact with physician for atherosclerosis
Pain or cramps in the calf (calves) when walking, which disappears within 10 minutes after
stopping
Arterial bypass or dotter procedure of the arteries of the abdomen or lower limb(s)
History of other arterial surgery
Use of prescribed drugs and/or regular contact with physician for diabetes
Angina pectoris and/or intermittent claudication (for definition: see cardiac disease and
atherosclerosis) without positive self report of cardiac disease and atherosclerosis
History of laser coagulation therapy of the retina (e)
Pain in legs and/or feet during rest
Use of prescribed drugs and/or regular contact with physician for stroke
History of _ 2 strokes
Limited in use of arms and/or legs because of stroke
Visual problems because of stroke
Problems with speech because of stroke
Problems understanding written text because of stroke
Use of prescribed drugs and/or regular contact with physician for rheumatoid arthritis/osteoarthritis
Pain in one or more joints during most days of past 3 months
Stiffness in one or more joints when getting up in the morning during most days of past 3 months
Swelling of one or more joints during most days of the past month
Complaints of one or more of the joints in toes, feet/ankles, knees or hips
Complaints of one or more of the joints in fingers, hands/wrists, elbows, shoulders or neck
History of surgery on one or more of the lower body joints because of arthritis
History of surgery on one or more of the upper body joints because of arthritis
Use of prescribed drugs and/or regular contact with physician for cancer
History of ¢ 2 primary malignant tumours
Non-melanoma skin cancer
Malignant melanoma, sarcomas, lymphomas, cancer of the breast, genitourinary tract (except the
ovaries), brain, larynx, colon or rectum
Leukaemia, cancer of the lungs, oesophagus, stomach, pancreas, liver, gall bladder or ovaries
Metastases in skeleton, liver, brain or lungs
Yes
Yes
Yes
Comorbidity (the presence of another chronic disease in addition to the index disease):
Chronic non-specific lung
disease + comorbidity
Cardiac disease + comorbidity
Atherosclerosis + comorbidity
Diabetes mellitus +
comorbidity
Stroke + comorbidity
Arthritis + comorbidity
Malignancies + comorbidity
All variables (except "prognostic category" in malignancies) are coded O=no and 1 =yes. When the index disease is coded 0, all disease specific variables are coded 0.
when all three activities could be performed
without difficulty, and 1 when the respondent
reported to have at least difficulty in perform-
ing one or more activities.
Potential confounders
Because of the associations of age and sex with
both the presence of specific chronic diseases
and with mobility limitations, both were
adjusted for in the analyses.
Medical treatment for the index disease was
considered a potential confounder because this
may influence the association between a
specific chronic disease and mobility in two
directions: people who are medically treated
may either have a lower odds for mobility
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149
184
150
249
151
30
542
481
259
240
33
138
16
18
80
262
205
183
84
52
147
194
34
14
53
138
100
38
68
29
31
22
981
418
609
477
233
792
610
184
39
248
167
25
37
185
26
11
207
62
71
1127
262
407
225
169
119
684
197
-, . 11
680 Kriegsnman, Deeg, van Eijk, Penninx, Boeke
limitations because of this treatment, or have a
higher odds when treatment has been started
because of relatively severe disease. For all spe-
cific index diseases, continuous medical treat-
ment was considered present when the patient
reported to use prescribed drugs, or to have
regular contact with a physician for the index
disease, or both.
Finally, to answer the second research ques-
tion, the presence of any other chronic disease
in addition to the index disease (comorbidity)
was adjusted for in the analyses as a potential
confounder. Comorbidity was operationalised
as a dichotomous variable and defined present
when either one or more of the other explicitly
asked diseases was present or the patient indi-
cated to have any other chronic disease, or
both.
ANALYSES
To answer the first research question, logistic
regression analysis was performed using the
total study sample. The analysis was adjusted
for age and sex. To compare the strengths of
the associations between specific chronic dis-
eases and mobility limitations, all specific
chronic diseases, including the category "other
chronic disease", were entered in the model
simultaneously.
To answer the second research question,
logistic regression analyses were performed for
each specific chronic disease separately. Sub-jects included in each model were those
without any chronic disease (reference group)
and those with at least the specific disease
studied (the index disease). For example, in the
logistic regression model examining the addi-
tional influence of parameters of clinical sever-
ity on the explanation of mobility limitations in
patients with cardiac disease, subjects included
were those who reported cardiac disease to be
present and those who reported no chronic
disease at all. Independent variables were
included in the models in four steps.
In the first step, the potential confounders
sex, age, and the presence of any other chronic
disease in addition to the index disease
(comorbidity) were entered. In the second step,
the index disease was entered. In the third step,
medical treatment for the index disease was
entered because of its role as a potential
confounder. Finally, in the fourth step the dis-
ease specific characteristics reflecting the clini-
cal severity of the index disease were consid-
ered for stepwise entry. Variables included in
this final step were entered into the model
when a significant contribution to the explana-
tion of mobility limitations was present
(pi,<0.05). These parameters of clinical disease
severity have an additional influence on mobil-
ity, conditional on self reported disease pres-
ence, when the final model is a significant
improvement compared with the previous one
that is adjusted for age, sex, comorbidity, and
medical care for the index disease. This isjudged by the change in -2 log likelihood and
the significance of its improvement from the
third to the fourth step.
The disease specific analyses may be sensi-
tive to the problem of colinearity because of
our decision to use the subjects without any
chronic disease as a reference group for all dis-
ease specific models. As a result, colinearitybetween the independent variables may havebeen introduced because the variables con-
cerning medical treatment, clinical disease
severity, and comorbidity could be scored onlyfor those subjects who reported the index
disease (in the reference group, these variables
are coded 0). To determine the extent to which
colinearity was present, additional logistic
regression analyses were performed for each of
the specific chronic diseases separately, includ-ing only those subjects who reported the index
disease. In these analyses, adjusted for the
potential confounders age, sex, comorbidity,
and medical treatment for the index disease,
the disease specific characteristics reflecting
clinical disease severity were considered for
stepwise entry as described before (fourth step
of the disease specific analyses). For each spe-
cific chronic disease, (the index diseases:
chronic non-specific lung disease, cardiac
disease, peripheral atherosclerosis, diabetes
mellitus, stroke, arthritis, and malignancies)
the strengths of the associations between the
disease specific characteristics and mobilitylimitations among the subjects with the index
disease were comparable to those resulting
from the analyses described in the previous
paragraph (in which the reference group of
subjects without any chronic disease was
included), as judged from the odds ratios and
95% confidence intervals. Thus, colinearity
was shown not to be an important problem in
the disease specific analyses.
It should be noted that subjects who
reported more than one chronic disease are
included in more than one regression model:
for instance, a person with diabetes mellitus
and chronic non-specific lung disease appears
both in the model with diabetes as the index
disease, and in that with chronic non-specific
lung disease as the index disease.
Results
Table 2 shows the background characteristics
of the study population. Table 3 shows the
results pertaining to the first research question.
Adjusted for age and sex, the presence of any of
the specific chronic diseases is significantly
associated with a higher odds for mobility limi-
tations, with odds ratios (ORs) varying from
1.38 for malignancies to 3.37 for arthritis (see
table 3). As was expected, stroke and arthritis
show the largest ORs (3.29 and 3.37, respec-
tively), followed by chronic non-specific lung
disease and cardiac disease (2.34 and 2.11,
respectively).
In table 4, the results are shown pertaining to
the second research question, concerning the
additional explanation of mobility limitations
by parameters of clinical disease severity. The
results of the disease specific logistic regression
analyses are presented for each step in the
analysis for each disease separately.
In subjects with chronic non-specific lung
disease, after adjustment for the potential con-
founders age, sex, and comorbidity, the
presence of chronic non-specific lung disease
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Table 2 Basic characteristics of the study population
(n=2830)
Determinants Number %
Sex
Male 1379 48.7
Female 1451 51.3
Age (y)
55-64 904 31.9
65-74 909 32.2
75 1017 35.9
Chronic diseases
Chronic non-specific lung disease 316 11.2
Cardiac disease 542 19.2
Peripheral atherosclerosis 262 9.3
Diabetes mellitus 205 7.2
Stroke 138 4.9
Arthritis 981 34.7
Malignancies 248 8.8
Other chronic diseases 1127 39.8
0 Chronic diseases 724 25.6
1 Chronic disease 960 33.9
¢2 Chronic diseases 1146 40.5
Mobility limitations
Walking up and down 15 steps
Without difficulty 2140 76.0
With difficulty 412 14.6
Only with help/not at all 265 9.4
Using own/public transportation
Without difficulty 2470 87.4
With difficulty 150 5.3
Only with help/not at all 206 7.3
Cutfing toenails
Without difficulty 2018 71.6
With difficulty 374 13.2
Only with help/not at all 428 15.2
Difficulty with _s 1 activity
No 1733 61.8
Yes 1072 38.2
Table 3 Results of multiple logistic regression analyses
(odds ratios and 95% confidence intervals) of age, sex, and
specific chronic diseases on mobility limitations in the total
study sample (ntO,=2805)
Number 95%
who Odds Confidence
replied yes ratios intervals
Age (per year) 1.10 1.09,1.11
Sex (female versus male) 1.76 1.45, 2.13
Chronic diseases (yes versus no)
Chronic non-specific
lung disease 316 2.34 1.76, 3.10
Cardiac disease 542 2.11 1.67, 2.68
Peripheral atherosclerosis 262 1.56 1.14, 1.97
Diabetes mellitus 205 1.89 1.33, 2.68
Stroke 138 3.29 2.10, 5.17
Arthritis 981 3.37 2.78, 4.07
Malignancies 248 1.38 1.02, 1.88
Other chronic disease 1127 1.92 1.60, 2.31
-2 log likelihood 2824.95
% predicted correctly 75.0
itself does not add significantly to the explana-
tion of mobility limitations, compared with
subjects without any chronic disease (step 2:
OR 1.49; 95% CI 0.70, 3.16). However, in
patients with chronic non-specific lung dis-
ease, medical treatment for the disease is an
explanatory factor with regard to the presence
of mobility limitations (step 3: OR 4.44; 95%
CI 2.40, 8.21). In addition to medical
treatment for chronic non-specific lung dis-
ease, a positive self report of shortness of
breath during light exertion or at rest (step 4:
OR 3.24; 95% CI 1.79, 5.86) and regular dis-
turbance of night rest resulting from chronic
non-specific lung disease (step 4: OR 3.65;
95% CI 1.12, 11.83) are associated with the
presence of mobility limitations. Thus, from
the model resulting after the final step, it seems
that the presence of mobility limitations in
chronic non-specific lung disease patients is
explained by shortness ofbreath and disturbed
night rest as parameters of clinical severity of
the disease, as well as by medical treatment for
the disease.
A self report of cardiac disease is an explana-
tory factor for mobility limitations in these
patients after adjustment for age, sex, and
comorbidity (step 2: OR 2.56; 95% CI 1.58,
4.15). However, the presence of cardiac disease
does not explain mobility limitations when
medical treatment is adjusted for (step 3: OR
1.03; 95% CI 0.47, 2.29). Medical treatment
for cardiac disease is an explanatory factor for
mobility limitations in cardiac patients (step 3:
OR 2.69; 95% CI 1.37, 5.31). Conditional on
the self reported presence of cardiac disease,
symptoms of angina pectoris (step 4: OR 2.03;
95% CI 1.33, 3.11) or congestive heart failure
(step 4: OR 1.98; 95% CI 1.19, 3.30) add to
the explanation of mobility limitations in
patients with cardiac disease. In the final
model, adjusted for angina pectoris and
congestive heart failure, medical treatment for
cardiac disease (either use of medication or
regular physician contacts), still adds to the
explanation of mobility limitations, irrespective
of the other variables in the model.
Adjusted for the potential confounders age,
sex, and comorbidity, peripheral atherosclero-
sis does not add significantly to the explanation
of mobility limitations (step 2: OR 0.66; 95%
CI 0.22,2.01). Also, in patients with peripheral
atherosclerosis, medical treatment and disease
specific characteristics do not add to the expla-
nation of mobility limitations.
Compared with subjects without any chronic
disease and adjusted for age, sex, and comor-
bidity, the self reported presence of diabetes is
an explanatory factor for mobility limitations
(step 2: OR 2.53; 95% CI 1.14, 5.62). Neither
medical treatment nor disease specific charac-
teristics of diabetes (diabetic complications)
have any additional influence on the explana-
tion of mobility limitations. However, the net
explanatory power of diabetes mellitus on
mobility limitations loses its significance, when
medical treatment is included in the regression
model (step 3: OR 2.21; 95% CI 0.43, 11.33).
In this case, colinearity between a self report of
diabetes and medical treatment is probably the
cause, because 95% of the subjects reporting
diabetes also reports to be medically treated for
the disease.
Adjusted for age, sex, and comorbidity, a
history of stroke explains the presence of
mobility limitations (step 2: OR 4.73; 95% CI
1.59, 14.05). This is particularly so for patients
who report to be medically treated for their
stroke (step 3: OR 2.96; 95% CI 1.13, 7.78).
Certain disease specific characteristics, apart
from medical treatment, significantly explain
the association between stroke and mobility
limitations. This applies to whether more than
one stroke occurred (step 4: OR 4.03; 95% CI
1.25, 13.04), and the presence of visual seque-
lae (step 4: OR 5.45; 95% CI 1.21, 24.59). The
presence of locomotor sequelae did not add
significantly to the explanation of mobility
limitations in stroke patients. Although this
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Table 4 Results of multiple logistic regression analyses of mobility limitations (odds ratios and 95% confidence intervals) on age, sex, comiorbidity and
disease specific characteristics in subjects with a specific chronic disease, compared with subjects without any chronic disease
Step 1 - enter Step 2 - eniter Step 3 - enter Step 4 - stepwise
nY, OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Chronic non-specific lung disease n,,,=1026
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Chronic non-specific lung disease
Medical treatment
Shortness of breath
Disturbed night rest
-2 log likelihood (p value
improvement)
'Y0 predicted correctly
Cardiac disease ni,,,=1243
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Cardiac disease
Medical treatment
Angina pectoris
Congestive heart failure
-2 log likelihood (p value
improvement)
% predicted correctly
Atherosclerosis n,,,,=980
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Atherosclerosis
Medical treatment
-2 log likelihood (p value
improvement)
% predicted correctly
Diabetes niellitus n,,,,=922
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Diabetes mellitus
Medical treatment
-2 log likelihood (p value
improvement)
% predicted correctly
Stroke n,,,,=852
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Stroke
Medical treatment
B 1 stroke
Visual sequelae
-2 log likelihood (p value
improvement)
% predicted correctly
Arthritis n,,,,=1681
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Arthritis
Medical treatment
Joint stiffness
Complaints lower body
Surgery lower body
-2 log likelihood (p value
improvement)
'/0 predicted correctly
Malignancies n,,,,=959
Age (per year)
Sex (female versus male)
Comorbidity (yes versus no)
Malignancies
Medical treatment
Haematogenous metastases
-2 log likelihood (p value
improvement)
'7, predicted correctly
262
316
229
150
30
1.12 1.10, 1.15 1.12 1.10, 1.15
1.72 1.21, 2.45 1.75 1.22, 2.49
12.21 8.47, 17.59 8.47 3.90, 18.43
1.49 0.70, 3.16
818.07
82.4
817.05
82.3
(NS)
1.11 1.09, 1.13 1.11 1.09, 1.13
1.78 1.32, 2.41 1.97 1.44, 2.70
8.12 6.01, 10.97 3.81 2.37, 6.15
2.56 1.58, 4.15
407
542
481
240
138
1091.00
80.3
1077.30
80.1
(<0.001)
1.13 1.11, 1.16 1.13 1.11, 1.16
2.09 1.44, 3.03 2.08 1.44, 3.02
11.18 7.58, 16.48 16.66 5.33, 52.06
0.66 0.22, 2.01
225
262
183
741.17
83.4
740.59
83.4
(NS)
1.14 1.11, 1.17 1.14 1.11, 1.17
2.36 1.60, 3.47 2.37 1.61, 3.50
9.44 6.16, 14.47 3.99 1.71, 9.30
2.53 1.14, 5.62
169
205
194
694.15
83.4
689.31
83.6
(<0.05)
1.14 1.11, 1.17 1.14 1.11, 1.17
1.91 1.26, 2.90 2.02 1.32, 3.08
15.77 9.21,26.99 3.56 1.11, 11.40
4.73 1.59, 14.05
119
138
100
38
29
684
981
418
477
792
184
609.20
85.5
1.12 1.10, 1.13
1.80 1.41, 2.30
5.89 4.63, 7.49
1660.63
75.9
1.13 1.10, 1.15
1.53 1.05, 2.21
7.69 5.21, 11.35197
248
167
11
759.07
82.1
602.15
85.5
(<0.01)
1.12 1.10, 1.14
1.52 1.18, 1.96
2.33 1.71, 3.18
4.62 3.26, 6.55
1584.61
76.9
1.13 1.10, 1.15
1.76 1.23, 2.52
10.68 4.76, 24.01
0.42 0.16, 1.09
4.44 2.40,8.21
793.73 (<0.0001)
83.0
1.11 1.09, 1.13
2.00 1.46,2.74
3.92 2.43, 6.34
1.03 0.47, 2.29
2.69 1.37,5.31
1068.74 (<0.01)
80.2
1.13 1.11, 1.16
2.14 1.47, 3.11
17.09 5.43, 53.80
0.46 0.14, 1.58
1.61 0.84, 3.09
738.53 (NS)
83.8
1.14 1.11, 1.17
2.38 1.61, 3.50
3.98 1.70, 9.28
2.21 0.43, 11.33
1.16 0.25, 5.29
689.27 (NS)
83.6
1.14 1.11, 1.17
2.00 1.31, 3.06
4.46 1.36, 14.64
1.86 0.47, 7.29
2.96 1.13, 7.78
597.36 (<0.05)
85.5
1.12 1.10, 1.14
1.46 1.13,1.88
2.28 1.67,3.11
3.73 2.58, 5.39
1.78 1.32, 2.40
(<0.0001) 1569.95 (<0.001)
77.5
1.13 1.10, 1.15
1.51 1.04, 2.19
6.00 2.60, 13.81
1.31 0.58, 2.94
758.66
82.1
(NS)
1.13 1.10, 1.15
1.49 1.03, 2.17
5.89 2.55, 13.60
1.52 0.60, 3.85
0.82 0.44, 1.53
758.28 (NS)
81.8
1.13 1.10, 1.16
1.72 1.19, 2.47
9.84 4.22, 22.95
0.31 0.11,0.86
3.03 1.58, 5.83
3.24 1.79, 5.86
3.65 1.12, 11.83
771.63 (<0.0001)
84.5
1.11 1.09, 1.13
1.86 1.35, 2.56
3.20 1.95, 5.26
0.84 0.37, 1.91
2.38 1.18, 4.80
2.03 1.33, 3.11
1.98 1.19, 3.30
1047.64 (<0.001)
80.6
1.13 1.11, 1.16
2.14 1.47,3.11
17.09 5.43, 53.80
0.46 0.14, 1.58
1.61 0.84, 3.09
738.53 (NS)
83.8
1.14 1.11, 1.17
2.38 1.61, 3.50
3.98 1.70, 9.28
2.21 0.43, 11.33
1.16 0.25, 5.29
689.27
83.6
(NS)
1.14 1.11, 1.18
2.07 1.35, 3.19
3.11 0.88,10.93
1.53 0.37, 6.37
2.58 0.97, 6.84
4.03 1.25, 13.04
5.45 1.21, 24.59
585.10
85.7
1.12
1.38
2.24
1.51
1.40
1.87
2.28
1.54
1525.79
78.8
1.13
1.55
5.90
1.51
0.75
4.99
754.10
82.1
(<0.01)
1.11, 1.14
1.06, 1.79
1.63, 3.08
0.93, 2.45
1.03, 1.92
1.37, 2.54
1.55, 3.34
1.02, 2.31
(<0.000 1)
1.10, 1.15
1.06, 2.25
2.55, 13.62
0.59, 3.83
0.40, 1.41
0.98, 25.54
(<0.05)
might have been caused by colinearity the lack and the presence of disease specific character-
of an association between the occurrence of istics reflecting clinical severity (step 4: OR
more than one stroke and locomotor sequelae 1.51; 95% CI 0.93, 2.45). In addition to the
renders this explanation unlikely. presence of medical treatment (step 4: OR
The association between arthritis and mobil- 1.40; 95% CI 1.03, 1.92), disease specific vari-
ity limitations (step 2: OR 4.62; 95% CI 3.26, ables that are associated with mobility limita-
6.55) is largely explained by medical treatment tions in arthritis patients are joint stiffness (step
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4: OR 1.87; 95% CI 1.37, 2.54), complaints of
the joints in the lower body (step 4: OR 2.28;
95% CI 1.55, 3.34), and a history of joint sur-
gery of the joints in the lower body, such as
total hip replacement (step 4: OR 1.54; 95% CI
1.02, 2.31).
Adjusted for age, sex, and comorbidity, a
history of cancer is not of influence on the
presence of mobility limitations (step 2: OR
1.31; 95% CI 0.58, 2.94). Moreover, neither
medical treatment nor disease specific charac-
teristics add to the explanation of mobility
limitations in subjects with a history of cancer,
compared with those without any chronic
disease. The only disease specific characteristic
that was of borderline significance in explain-
ing mobility limitations among cancer patients,
was the presence ofhaematogenous metastases
(step 4: OR 4.99; 95% CI 0.98, 25.54), but the
number of patients with metastases is small
(n= 11). We also performed the analyses with
exclusion of those subjects with a history of
non-melanoma skin cancer, but these results
did not differ from those including all cancer
patients.
Discussion
In the total study sample, each self reported
chronic disease is significantly associated with
the presence of mobility limitations. As ex-
pected, the strongest associations are found for
chronic diseases of which the clinical picture
includes disability (stroke and arthritis), or that
are generally associated with decreased endur-
ance capacity (chronic non-specific lung dis-
ease and cardiac disease). This finding is
consistent with results from previous
studies.2 69
This study, however, shows that the self
reported presence of specific chronic diseases is
too crude a measure to be sufficiently accurate
in explaining the presence of mobility limita-
tions. After adjustment for the potential
confounders age, sex, and comorbidity, the
associations between the specific chronic dis-
eases and mobility limitations seem to be
largely explained by disease specific character-
istics (including medical treatment for the
index disease) reflecting clinical severity of the
disease.
Symptoms explaning mobility limitations in
case of a positive self report of chronic
non-specific lung disease (shortness of breath
during light exertion, and regular disturbance
ofnight rest) are associated with a continuously
decreased endurance tolerance. This is not the
case for the other symptoms of chronic
non-specific lung disease (for example, cough-
ing and wheezing), which are, at the most, only
limiting during an episode. In addition, comor-
bidity and medical treatment for chronic non-
specific lung disease were shown to be
explanatory factors for mobility limitations in
patients with chronic non-specific lung disease.
Thus, the association of chronic non-specific
lung disease with mobility limitations can be
explained by parameters of clinical disease
severity (shortness of breath and disturbed
night rest, as well as medical treatment) and the
presence of other chronic diseases in addition
to the chronic non-specific lung disease.
For cardiac disease, symptoms of angina
pectoris and congestive heart failure, both
associated with decreased endurance capacity,
added significantly to the explanation of
mobility limitations, whereas the other charac-
teristics studied (such as a history of myocar-
dial infarction or cardiac surgery) did not. The
association between the self reported presence
of cardiac disease and mobility limitations
seems to be explained completely by medical
treatment and specific cardiac diagnoses in-
dicative of the clinical severity (angina pectoris
and congestive heart failure), as well as by the
presence of comorbidity.
For atherosclerosis, disease specific charac-
teristics did not add to the explanation of
mobility limitations. For peripheral atheroscle-
rosis, it has been shown that the accuracy of
patients' self reports, compared with general
practitioners' information, is low.'0 Therefore,
it might be expected that symptoms would add
to the explanation ofmobility limitations in this
chronic disease, but this was not the case. Rel-
evant bias can be suspected because of
confusion between the Dutch words "slagad-
eren" (arteries) and "spataderen" (varicose
veins, venous insufficiency). Venous insuffi-
ciency may also be associated with mobility
limitations, but symptoms are different from
those of peripheral atherosclerosis. The ex-
planatory power of comorbidity on mobility
limitations in patients reporting peripheral
atherosclerosis is high, compared with that in
patients with other index diseases.
In patients with diabetes mellitus, disease
specific characteristics reflecting clinical sever-
ity (that is, the presence of microvascular and
macrovascular complications) did not add sig-
nificantly to the explanation of mobility limita-
tions. The possibility that these disease specific
characteristics, particularly macrovascular
complications, could be shown to influence the
explanation of mobility limitations in diabetes
mellitus, was diminished by the decision not to
consider the additional presence of a selfreport
of cardiac disease or atherosclerosis as manifes-
tations of macrovascular complications, but to
include these as comorbidity. The prevalence
of cardiac disease and peripheral atherosclero-
sis among patients with diabetes mellitus was
high, compared with the prevalence in the total
sample (28.8% versus 19.2% for cardiac
disease, 19.0% versus 9.3% for atherosclero-
sis), and compared with the prevalence of
macrovascular complications in diabetic pa-
tients (16.6%). In contrast with the disease
specific complications, the presence of comor-
bidity adds to the explanation of mobility limi-
tations in patients with diabetes mellitus. The
fact that virtually all diabetic patients are
medically treated for the disease, which intro-
duces the problem ofcolinearity in the analysis,
probably explains why the association of diabe-
tes mellitus with mobility limitations is not sig-
nificant anymore, once medical treatment is
entered as a potential confounder.
In contrast with expectations, the presence
of locomotor sequelae in stroke patients did
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not add to the explanation of mobility
limitations. Although the prevalence of this
symptom is high (49.3%), a history of more
than one stroke and the presence of visual
sequelae, which were both not associated with
the presence of locomotor sequelae, seem to be
more important. These aspects of clinical
severity largely explain the association between
stroke and mobility limitations. In contrast
with the results in the other index diseases,
comorbidity offers no additional explanation.
In patients with arthritis, affliction of the
lower body joints has the largest explanatory
power on mobility limitations, as would be
expected considering the content of the mobil-
ity items included. Also, a history of lower body
joint surgery (an intervention with the purpose
of restoring function and alleviating symp-
toms) adds to the explanation of mobility limi-
tations. The conclusion that can be drawn from
this cross sectional analysis is that, although
joint surgery undoubtedly has a beneficial
influence on functioning and symptoms, mo-
bility is not restored fully, compared with peo-
ple of the same age and sex, but without
chronic diseases. The association between
arthritis and mobility limitations is thus
explained by certain parameters of disease
severity (joint stiffness, complaints of lower
body joints, and a history of surgery on the
lower body joints), as well as by continuous
medical treatment and the presence of comor-
bidity.
The cross sectional design of this study is a
possible explanation for the negative results we
found for patients with a history of cancer: in
all prognostic categories, only survivors are
included (the mean duration of time since
diagnosis was approximately eight years). In
the absence of haematogenous metastases and
additional chronic diseases, the initial severity
of cancer (as reflected by the prognostic
category) does not add to the explanation of
mobility limitations.
Medical treatment was adjusted for, because
it was expected that the associations between
the specific index diseases and mobility could
be modified by treatment in both directions.
However, when medical treatment was of
influence (in chronic non-specific lung disease,
cardiac disease, and arthritis), it was consist-
ently associated with a higher odds for mobility
limitations. A possible explanation is that only
patients with comparativley severe chronic
non-specific lung disease, cardiac disease or
arthritis will receive continuous medical treat-
ment (medication or regular check ups by a
physician). Although their symptoms may be
alleviated to a great extent, they may still expe-
rience mobility limitations more often than
people with less severe disease. For those
diseases for which continuous medical treat-
ment is the rule, such as diabetes mellitus,
stroke or cancer, inclusion of medical treat-
ment in the model will not add significantly to
the explanation of mobility limitations because
of its low variance among patients.
As described in the methods section, our
study population is a comparatively healthy
selection of the original sample, which may
have caused an underestimation of the ob-
served associations.
Summarising, this study provides evidence
that a more accurate explanation of the
associations between specific chronic diseases
and mobility limitations can be obtained by
including questions on medical treatment and
disease specific signs and symptoms reflecting
clinical disease severity, conditional on a
positive self report of the index disease. This
method of acquiring additional information
reflecting the clinical severity of chronic
diseases provides a cost saving alternative for
other methods that are frequently used, such as
medical record extraction,20 22 laboratory
tests,23 or clinical examination.21 For large scale
population surveys, the organisational and
financial demands associated with the use of
these methods will often exceed the available
resources. Moreover, there may be some doubt
as to whether these measures, which are often
developed in specific clinical settings, are
equally applicable in the general population.
Our results also provide evidence supporting
the usefulness of distinguishing between spe-
cific chronic diseases when studying the impact
of disease on aspects of physical functioning,
such as the presence of mobility limitations,
instead of using measures in which the
information about the specific chronic diseases
is pooled into one overall score, as is the case
for many other measures of disease
severity.22 25-28 Use of pooled information ex-
cludes the possibility to investigate the impact
of a specific chronic disease on the outcome
that is being studied, be it mobility, mortality or
the use of health care facilities.
In view of our results, future predictions
regarding the prevalence of mobility limitations
may have to be adjusted, but additional investi-
gations are needed to determine to what
extent. Currently, predictions are mostly com-
puted using trends in the prevalences of self
reported presence of diseases and mobility
limitations. The most important gain of this
study, compared with previous ones, is that it is
shown that the presence of disease specific
characteristics reflecting clinical severity in
patients with a specific chronic disease, rather
than only the positive self report of a disease,
explains the presence of mobility limitations.
The use of this type of additional information,
reflecting the clinical severity of a disease, may
increase the accuracy of future predictions
regarding the development of the prevalence of
mobility limitations or disability. Moreover,
differences between studies on the associations
between chronic diseases and physical func-
tioning may be explained by differences in the
prevalences of disease specific signs and symp-
toms in diagnosed and treated patients. For
instance, the conflicting evidence with regard
to future developments of disability free life
expectancy as far as "compression" or "decom-
pression" of morbidity is concerned29 34 may
partly result from a different distribution of
clinical disease severity (in other words, differ-
ent prevalences of signs and symptoms) across
countries. Differences in this distribution may,
for example, reflect differences in the extent to
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which diseases are diagnosed in early stages (a
large proportion of diseases diagnosed by
screening may result in relatively more people
with less severe disease). From a longitudinal
perspective, using information on both the
presence of chronic diseases and on disease
specific characteristics reflecting clinical dis-
ease severity, makes it possible for future
predictions to take into account the effects of
changes in the distribution of clinical severity
of specific chronic diseases. The occurrence of
these type of changes is likely to occur. For
example, increases in the early detection of
chronic diseases and improvements in medical
treatment for these early stages, including
treatment of risk factors for other diseases
(such as treatment of hypertension to prevent
cardiovascular and cerebrovascular disease)
may lead to a shift of the distribution of clinical
severity towards less severe disease, and to a
decrease in the associations of specific chronic
diseases with disability when the changes in
clinical severity are not taken into account.
This study is based on data collected in the context of the Lon-
gitudinal Aging Study Amsterdam (LASA), conducted at the
Department of Psychiatry and the Department of Sociology and
Social Gerontology of the Vrije Universiteit, Amsterdam, the
Netherlands.
Funding: LASA is largely funded by the Ministry of Health,
Welfare and Sports of the Dutch Government.
Conflicts of interest: none.
1 Cornoni-Huntley JC, Foley DJ, Guralnik JM. Co-morbidity
analysis: a strategy for understanding mortality, disability
and use of health care facility of older people. Int _7
Epidenil ol 1991 ;20 (suppl l):S8-17.
2 Verbrugge LM, Lepkowski JM, Imanaka Y Comorbidity
and its impact on disability. Milbank Q 1989;67:450-84.
3 Guralnik JM, LaCroix AZ, Everett DF. Comorbidity of
chronic conditions and disability among older persons
United States, 1984. Amn Med Assoc 1990;263:209-10.
4 Guralnik JM, LaCroix AZ, Abbott RD, et al. Maintaining
mobility in late life. I. Demographic characteristics and
chronic conditions. Am ]f Epidemiol 1993;137:845-57.
5 Verbrugge LM, Lepkowski JM, Konkol LL. Levels of
disability among US adults with arthritis. Gerontol 1991;
46:S71-83.
6 Boult C, Kane RL, Louis TA, Boult L, McCaffrey D.
Chronic conditions that lead to functional limitation in the
elderly. ]f Gerontol 1994;49:M28-36.
7 Guccione AA, Felson DT, Anderson JJ, et al. The effects of
specific medical conditions on the functional limitations of
elders in the Framingham study. Am
_7 Publ Health
1994;84:351-8.
8 Bos GAM van den. The burden of chronic diseases in terms
of disability, use of health care and healthy life expectan-
cies. Eur] Publ Health 1995;5:29-34.
9 Verbrugge LM. New thinking and science on disability in
mid- and late life. Eur7Publ Health 1995;5:20-8.
10 Kriegsman DMW, Penninx BWJH, Eijk JThM van, Boeke
AJP, Deeg DJH. Self-reports and general practitioner
information on the presence of chronic diseases in commu-
nity dwelling elderly: a study on the accuracy of patients'
self-reports and on determinants of inaccuracy.
_7 Clin Epi-
demniol 1996;49: 1407-17.
11 Harlow SD, Linet MS. Agreement between questionnaire
data and medical records. The evidence for accuracy of
recall. Am ]f Epidemniol 1989; 129:233-48.
12 Bos GAM van den. Care for the chronically ill. (In Dutch:
Zorgen van en voor chronisch zieken). [PhD thesis].
Amsterdam: Bohn, Scheltema and Holkema, 1989.
13 Kehoe R, Wu S-Y, Leske MC, Chylack LT. Comparing self-
reported and physician-reported medical history. Amn
Epidemiol 1994;139:813-8.
14 Deeg DJH, Knipscheer CPM, Tilburg W van, eds.
Autononmy anid well-being in the aginlg populationz. Conicepts anzd
design of the Longitudinal Aging Study Amsterdamii. Bunnik:
Netherlands Institute for Gerontology, 1993.
15 Broese van Groenou MI, Tilburg TG van, Leeuw ED de,
Liefbroer AC. Data collection. In: Knipscheer CPM, Jong-
Gierveld J de, Tilburg TG van, Dykstra PA, eds. Living
arrangenmenits and social tnetworks of older adults. First results.
Amsterdam: VU University Press, 1995:185-97.
16 Smit JH, Vries MZ de. Procedures and results of the field
work. In: Deeg DJH, Westendorp-de Serriere M, eds.
Autonomy, and well-being in the aging populationi. I. Report
fronm the Lonigitudinal Aginzg Study Anmsterdanm 1992-1993.
Amsterdam: VU University Press, 1994:7-13.
17 Rose GA. The diagnosis of ischaemic heart pain and inter-
mittent claudication in field surveys. Bzull World Health Org
1962;27:645-58.
18 Perez CA, Brady LW, eds. Prilciples anid practice of radiation
oncology. Philadelphia: Lippincott, 1992.
19 Deeg DJH, Kriegsman DMW, Zonneveld RJ van. Preva-
lence of four chronic conditions and their association with
health limitations in older persons in The Netherlands,
1956-1993. (In Dutch: Prevalentie van vier chronische
ziekten en hun samenhang met gezondheidsbeperkingen
bij ouderen in Nederland, 1956-1993). Tijdschr Soc
Gezondheidsz 1994;72:434-41.
20 Asenjo MA, Bare L, Bayas JM, et al. Relationship between
severity, costs and claims of hospitalized patients using the
Severity of Illness Index. Eur]7 Epidemtiol 1994;10:625-32.
21 Hartz AJ, Guse C, Sigmann P, Krakauer H, Goldman RS,
Hagen TC. Severity of illness measures derived from the
Uniform Clinical Data Set (UCDSS). Med Care 1994;32:
881-901.
22 Parkerson GR, Broadhead WE, Tse CJ. The Duke Severity
of Illness Checklist (DUSOI) for measurement of severity
and comorbidity. Clin Epidemiol 1993;46:379-93.
23 Damiano AM, Bergner M, Draper EA, Knaus WA, Wagner
DP. Reliability of a measure of severity of illness: acute
physiology of chronic health evaluation - II. Clin Epidemiol
1992;45:93-101.
24 Kalra L, Dale P, Crome P. Evaluation of a clinical score for
prognostic classification of elderly stroke patients. Age Age-
ing 1994;23:492-98.
25 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new
method of classifying prognostic comorbidity in longitudi-
nal studies: development and validation.] Chron Dis 1987;
40:373-83.
26 Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of
a combined comorbidity index. _ Clin Epidemiol 1994;47:
1245-51.
27 Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation
of the Cumulative Illness Rating Scale in a geriatric
residential population. Arn Geriatr Soc 1995;43: 130-7.
28 Waite K, Oddone E, Weinberger M, Samsa G, Foy M,
Henderson W. Lack of association between patients' meas-
ured burden of disease and risk for hospital readmission.]
Clin Epideniol 1994;47:1229-36.
29 Verbrugge LM. Recent, present and future health of Ameri-
can adults. Annu Rev Public Health 1989;10:333-61.
30 Olshansky SJ, Ault AB. The fourth stage of the epidemio-
logic transition: the age of delayed degenerative diseases.
Milbank Q 1986;64:355-91.
31 Manton KG, Corder LS, Stallard E. Estimates of change in
chronic disability and institutional incidence and preva-
lence rates in the US elderly population from the 1982,
1984, and 1989 National Long Term Care Survey. _7
Gerontol 1993;48:S 153-66.
32 Roos NP, Havens B, Black C. Living longer but doing
worse: assessing health status in elderly persons at two
points in time in Manitoba, Canada, 1971 and 1983. Soc
SciMed 1993;36:273-82.
33 Corder LS. Improving survey measurement: health status
transitions in a longitudinal list sample design. In: Mathers
C, McCallum J, Robine J-M, eds. Advances in health
expectancies: proceedinzgs of the 7'" meeting of the International
Network on Health Expectancy (REVES), Canberra, February
1994. Canberra: Australian Institute of Health and
Welfare, 1994:408-23.
34 Verbrugge LM. The experience and measure of disability.
In: Mathers C, McCallum J, Robine J-M, eds. Advances in
health expectancies: proceedings of the 7' nmeeting of the
International Network on Health Expectancy (REVES), Can-
berra, February 1994. Canberra: Australian Institute of
Health and Welfare, 1994:19-33.
